DE SB118

Authorizes pharmacists to substitute FDA-approved interchangeable biosimilar biological products for prescribed biological reference products unless the prescriber marks the prescription "Brand Necessary" or "Brand Medically Necessary"

Requires pharmacists to notify patients in writing that a biosimilar product has been dispensed and notify the prescriber electronically, by fax, in writing, or by phone within 48 hours of dispensing

Mandates pharmacists record on the prescription label and dispensing record the product name of the biosimilar, that it was substituted for the original product, and the manufacturer's name

Requires pharmacists to maintain records of all biosimilar substitutions for at least 3 years after the dispensing date

Provides liability protections for pharmacists who substitute interchangeable biosimilar products in compliance with this section